Director James R. Tobin filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 41,666 shares of Globus Medical Inc. common stock, to be acquired through a cashless stock option exercise on the same date.
Invesco Ltd. filed a Schedule 13G with the SEC on November 10, 2026, reporting beneficial ownership of 8,517,786 shares of Cognex Corp common stock as of September 30, 2026.
Cincinnati Financial Corp President and CEO Stephen M. Spray filed a Form 4 on November 9, 2026, disclosing a gift of 55,000 shares of common stock to his spouse on November 6, 2026, for estate planning purposes.
Grayscale's Zcash ETF, trading under the ticker ZCSH, submitted a free writing prospectus (FWP) with the SEC on November 10, 2026, in connection with an ongoing offering under Registration No. 333-291800.
Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., filed a free writing prospectus on November 10, 2026, disclosing preliminary terms for 3-year autocallable contingent coupon securities linked to the worst of the Dow Jones Industrial Average, the Nasdaq-100 Index, and the S&P 500 …
Invesco Ltd. filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 6,294,677 shares of Clorox Co/The common stock, representing 5.2% of the class, as of September 30, 2026.
Shana Allen, Chief Information Officer and Executive Vice President of FS Bancorp, Inc., filed a Form 4 on November 10, 2026, disclosing the acquisition of 34.4432 shares of common stock on November 6, 2026, through the company's Nonqualified 2022 Stock Purchase Plan.
Invesco Ltd. filed an amended Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 1,852,539 shares of Charles River Laboratories International Inc as of September 30, 2026.
Octopus Head, Inc., 415 Foundation, and Witold Stankiewicz filed Amendment No. 2 to a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 5,400,000 shares of Expensify, Inc. Class A Common Stock as of September 23, 2026.
Curaleaf Holdings, Inc. filed a current report on November 10, 2026, disclosing that it has received all required competition law clearances for its proposed acquisition of Aurora Cannabis.